ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
US Tech 100
19,884.80
0.46%
Dow Jones
40,211.72
0.53%
Brent Oil
83.94
-0.47%
Bitcoin
63,613.36
-1.91%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Centogene NV (CNTG) Quote

Centogene NV

Centogene NV (CNTG)

NASDAQ
0.54
0.0249
(4.83%)
Closed July 16 4:00PM
Delayed by 15 minutes
0.54
0.00
(0.00%)
After Hours: 6:18PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.54
Bid
0.49
Ask
0.55
Volume
128,929
0.525 Day's Range 0.55
0.34 52 Week Range 1.53
Market Cap
14.215M
Previous Close
0.515101
Open
0.525
Last Trade
5
@
0.53
Last Trade Time
Financial Volume
$ 69,351
VWAP
0.537904
Average Volume (3m)
172,591
Shares Outstanding
27,595,835
Dividend Yield
-
PE Ratio
-0.42
Earnings Per Share (EPS)
-1.29
Revenue
48.54M
Net Profit
-35.53M

About Centogene NV

Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a... Centogene NV is a United States-based company focused on transforming clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. The company operates in three segments: pharmaceutical, diagnostics, and COVID-19. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its clinical diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Show more

Sector
Medical Laboratories
Industry
Medical Laboratories
Website
www.centogene.com
Headquarters
Rostock, Deu
Founded
1970
Centogene NV is listed in the Medical Laboratories sector of the NASDAQ with ticker CNTG. The last closing price for Centogene NV was $0.52. Over the last year, Centogene NV shares have traded in a share price range of $ 0.34 to $ 1.53.

Centogene NV currently has 27,595,835 shares outstanding. The market capitalization of Centogene NV is $14.21 million. Centogene NV has a price to earnings ratio (PE ratio) of -0.42.

CNTG Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

June 20 2024
Edgar (US Regulatory)

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path), a leader in forming collaborations that accelerate drug...

June 20 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 31 2024
Edgar (US Regulatory)

CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 31, 2024 (GLOBE NEWSWIRE) -- CENTOGENE N.V. (Nasdaq: CNTG) (the “Company”), the essential life science partner for data-driven answers in...

May 31 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

May 29 2024
Edgar (US Regulatory)

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

May 17 2024
Edgar (US Regulatory)

CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights

Reported Full Year 2023 total revenues of 2% growth at €48.5 millionSecured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company...

May 15 2024
GlobeNewswire Inc.

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

May 15 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0817.39130434780.460.550.4235357590.48909334CS
40.17547.94520547950.3650.550.359981180.41321108CS
120.07716.63066954640.4630.55440.341725910.39872551CS
26-0.65-54.62184873951.191.250.341058680.48024479CS
52-0.93-63.26530612241.471.530.34647670.62198838CS
156-10.67-95.182872435311.2111.750.342040951.53699091CS
260-13.56-96.17021276614.1360.341607943.64241532CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
SHOTWSafety Shot Inc
$ 0.41
(115.79%)
7.56k
DATSDatChat Inc
$ 1.89
(81.73%)
54.75M
CYNCYNGN Inc
$ 9.18
(53.77%)
17.79M
SCNIScinai Immunotherapeutics Ltd
$ 5.80
(42.86%)
29.37M
ASLNASLAN Pharmaceuticals Ltd
$ 1.36
(-46.67%)
1.16M
KZIAKazia Therapeutics Ltd
$ 0.5593
(-37.56%)
15.34M
LCFYLocafy Ltd
$ 3.5597
(-36.32%)
584.38k
NAASNaaS Technology Inc
$ 2.82
(-33.02%)
1.94M
ZENVZenvia Inc
$ 1.67
(-26.75%)
658.26k
FFIEFaraday Future Intelligent Electric Inc
$ 0.5152
(22.09%)
217.92M
NVDANVIDIA Corporation
$ 128.44
(-0.62%)
208.32M
SQQQProShares UltraPro Short QQQ
$ 7.46
(-0.67%)
155.14M
AMIXAutonomix Medical Inc
$ 1.3701
(121.70%)
154.81M
TSLATesla Inc
$ 252.64
(1.78%)
147.31M

CNTG Discussion

View Posts
Termite7 Termite7 2 months ago
Good news!!!
👍️0
Awl416 Awl416 2 months ago
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
👍️0
LessIsMore LessIsMore 12 months ago
CNTG built a position in this stock over the last several weeks. Seems like there's lots to like EXCEPT for the fact that we have a low volume stock with an anxious seller.
👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: More news; this could run.

https://www.prnewswire.com/news-releases/lifera-and-centogene-enter-strategic-collaboration--forming-saudi-arabian-joint-venture-to-increase-access-to-leading-data-driven-multiomic-testing-301866231.html#:~:text=Lifera%20and%20CENTOGENE%2C%20Enter%20Strategic,Leading%20Data%2DDriven%20Multiomic%20Testing
👍️0
Triple nickle Triple nickle 1 year ago
Iffy right here
👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: See the NEW 'Chart' on this, below!!!!

👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: Here's that news!!! (See below!!!)

👍️0
TheFinalCD TheFinalCD 1 year ago
CNTG NEWS https://finance.yahoo.com/news/centogene-lifera-biopharma-company-owned-113000204.html

https://finviz.com/quote.ashx?t=CNTG&ty=c&ta=1&p=d


CENTOGENE will receive a $30 million investment in the form of a mandatory convertible loan with a six-month term and a conversion price of $2.20 per share of CENTOGENE’s common stock, as well as significant JV performance-related milestone payments and revenue-based royalties until the year 2033
👍️0
Jess070283 Jess070283 1 year ago
Warming up After Hours…
👍️0
TheFinalCD TheFinalCD 1 year ago
CONGRAT$
👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: I gots tah PASS on this creepy stock!!! My E-Turd could not even do the MATH!!! (I'll get suckered!!) CONGRATS TO THOSE WHO ALREADY SCORED!!!
👍️0
gozz1254 gozz1254 1 year ago
Halted again eom
👍️0
Jess070283 Jess070283 1 year ago
Ok the dip has ripped.!$$$$
👍️0
Jess070283 Jess070283 1 year ago
Loading this dip for the rip…
👍️0
Invest-in-America Invest-in-America 1 year ago
CNTG: Ooooops!!! And here we go, AGAIN!!
👍️0
catty catty 2 years ago
makinezmoney: thanks, but I 'm not king on any new posiitions
👍️0
makinezmoney makinezmoney 2 years ago
$CNTG: BIggggggg spike here at 0.94

Awaken the KRAKEN !!!!!!!!!


Lets see whats about to go down here.......................

https://www.centogene.com/

https://finance.yahoo.com/news/centogene-reaches-12-500-patient-120000034.html


GO $CNTG
👍️0
catty catty 4 years ago
since test is available on AMZN in Germany, hopefully it'll be approved to be sold by them in the USA
👍️0
catty catty 4 years ago
Fox Business covered CNTG this morning. Just took a small position. Intend to be out of most of my stocks before election, except for the COVID-19 ones, including ZM
👍️0
Timetravelerdos Timetravelerdos 4 years ago
CENTOGENE Announces Convenient At-Home Coronavirus Test Solution Now Available in Germany on Online Marketplace!

CENTOGENE announces test kits for the detection of SARS-CoV-2 virus RNA now available on Amazon in Germany - the first of its type offered on the online marketplace
Offering includes delivery of a full, safe, and high-quality COVID-19 testing solution - significantly broadening access to the Company's innovative tests
Short process times and digital transmission of reports deliver results directly to the customer
Tests validated on the basis of the World Health Organization's (WHO)/Charite's reference guidelines

https://finance.yahoo.com/news/centogene-announces-convenient-home-coronavirus-063000951.html

👍️0
rstar rstar 4 years ago
right? and already doing rapid testing for lufthansa at frankfurt airport- and FDA EUA approved and partnered for school testing in US.

surprised not moving back to highs yet...
👍️0
Timetravelerdos Timetravelerdos 4 years ago
AT Home Testing...No Brainer This is Huge !!! Go CNTG ! Approved by World Health Organization !!
👍️0
rstar rstar 4 years ago
at home testing through amazon in germany~ boom! 14.30

i see new highs coming soon

$CNTG!
👍️0

Your Recent History

NASDAQ
CNTG
Centogene NV
NASDAQ
JVA
Coffee
BOV
LOGG3
LOG Commercial ON
NYSE
BWA
BorgWarner
NASDAQ
PCSA
Processa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved